Anacetrapib (MK-0859)

Catalog No. A11084

Anacetrapib (MK-0859)是一种有效的,选择性,可逆的rhCETP和突变CETP(C13S)抑制剂,IC50分别为7.9 nM和11.8 nM,提高HDL-C,降低LDL-C,不提高醛固酮和血压。
Catalog Num A11084
M. Wt 637.5
Formula C30H25F10NO3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 875446-37-0
Synonyms MK0859
SMILES C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
Anacetrapib (MK-0859)是一种有效的,选择性,可逆的rhCETP和突变CETP(C13S)抑制剂,IC50分别为7.9 nM和11.8 nM,提高HDL-C,降低LDL-C,不提高醛固酮和血压。
In vitro (25°C) DMSO 108 mg/mL (169.41 mM)
Water Insoluble
Ethanol 108 mg/mL (169.41 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 9 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 15.69 mL 78.43 mL 156.86 mL
0.5 mM 3.14 mL 15.69 mL 31.37 mL
1 mM 1.57 mL 7.84 mL 15.69 mL
5 mM 0.31 mL 1.57 mL 3.14 mL

*The above data is based on the productmolecular weight 637.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.